Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current risk for transfusion transmitted infections.

Roger Y Dodd1

  • 1Research and Development, American Red Cross, Rockville, Maryland 20855, USA. dodd@usa.redcross.org

Current Opinion in Hematology
|September 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-time blood donor demographics and characteristics during the individual donor assessment versus 3-month deferral policies for high-risk behaviors.

Transfusion·2026
Same author

Prevalence of HIV, HBV, and HCV in United States blood donations, 2015-2023: The transfusion-transmissible infections monitoring system (TTIMS).

Transfusion·2025
Same author

Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion-transmissible infections monitoring system.

Transfusion·2025
Same author

Reinstatement and infectious disease rates among blood donors previously deferred under men who have sex with men time-based deferral.

Transfusion·2025
Same author

An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 1: Participation rates and the presence of laws, regulations, standards and best practices.

Vox sanguinis·2025
Same author

An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance.

Vox sanguinis·2025
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Blood transfusion safety is improving due to better interventions and public health. However, vigilance against emerging infectious agents remains crucial as new threats may lack preventive measures.

Area of Science:

  • Transfusion Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Blood safety is a primary concern in transfusion medicine.
  • Ongoing efforts aim to minimize infectious agent transmission via blood products.
  • Emerging infections pose a continuous threat to transfusion safety, necessitating periodic risk reassessment.

Purpose of the Study:

  • To review the current risks associated with transfusion-transmitted infections.
  • To highlight advancements in blood safety interventions.
  • To address the challenge of emerging infectious agents in transfusion medicine.

Main Methods:

  • Review of recent scientific literature on transfusion-transmitted infections.
  • Analysis of trends in the incidence of known transfusion-transmissible pathogens.

Related Experiment Videos

  • Evaluation of new donor screening methods and emerging infectious threats.

    • Main Results:

    • Significant decline in the risk of major transfusion-transmissible infections.
    • Implementation of new donor testing for West Nile virus and Trypanosoma cruzi.
    • Confirmation of variant Creutzfeldt-Jakob disease transmission via transfusion and ongoing research into other agents.

    Conclusions:

    • Transfusion-transmitted hepatitis viruses and retroviruses pose a minimal risk.
    • Clinicians must remain aware of emerging infectious agents.
    • Preventive measures may not always be available for novel infections, requiring ongoing surveillance.